SASanaz Ansarifar

Sanaz Ansarifar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanaz Ansarifar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Learning a threat converges on the circuit processing innate threat

    by Noëmie Mermet-Joret, Milad Nazari, Andreas T. Pommer, Sanaz Ansarifar, Joana Silva Luz, Anne-Katrine Vestergaard, Sadegh Nabavi

    A prevailing view in affective neuroscience holds that innate and learned behaviors are processed through distinct neuroanatomical pathways, one pre-wired, the other running on synaptic plasticity. However, here we show that processing innate and learned threats in the lateral amygdala deviates fundamentally from this view. We tracked the three core elements of circuit function—excitatory neurons, inhibitory neurons, and neuromodulators—in mice, as they were exposed to an innately aversive looming stimulus and as they learned a cued threat. Tracking the same neurons across sessions, revealed a subpopulation of excitatory neurons recruited by the innate threat that was preferentially potentiated following auditory threat learning. Furthermore, both forms of threat converged on the same modulatory mechanisms: the disinhibitory VIP–SST motif and norepinephrine release, but with a critical difference. While the innately aversive stimulus possessed privileged access to these pathways, the learned cue acquired access through synaptic plasticity. In this instance, learning about a new threat apparently recruits a circuit that protects animals from natural threats.

  • Open Access

    Semaglutide alters behaviour and nucleus accumbens oscillatory activity in healthy mice

    by Alejo Mosqueira, Sanaz Ansarifar, Sadegh Nabavi, Andrea Moreno

    Semaglutide, a GLP-1 receptor agonist, is widely studied in metabolic disorders, yet its effects in healthy subjects remain unclear. Here, we show that daily administration of semaglutide (0.1 mg/kg) in healthy mice alters behaviour in various tests related to stress and reward pursuit. Additionally, acute administration of semaglutide changes the oscillatory activity in the nucleus accumbens in the delta, theta and alpha bands. These findings reveal that semaglutide impacts both behaviour and neural dynamics in non-diseased brains, offering a baseline for interpreting its broader therapeutic potential.

  • Open Access

    Semaglutide Alters Behaviour and Nucleus Accumbens Oscillatory Activity in Healthy Mice

    by Alejo Mosqueira, Sanaz Ansarifar, Sadegh Nabavi, Andrea Moreno

    SUMMARY: Semaglutide, a GLP-1 receptor agonist, is widely studied in metabolic disorders, yet its effects in healthy subjects remain unclear. Here, we show that daily administration of semaglutide (0.1 mg/kg) in healthy mice alters behaviour in various tests related to stress and reward pursuit. Additionally, acute administration of semaglutide changes the oscillatory activity in the nucleus accumbens in the delta, theta and alpha bands. These findings reveal that semaglutide impacts both behaviour and neural dynamics in non-diseased brains, offering a baseline for interpreting its broader therapeutic potential.


  • Open Access

    Impact of volume and expression time in an AAV-delivered channelrhodopsin

    by Sanaz Ansarifar, Gabija Andreikė, Milad Nazari, Rodrigo Labouriau, Sadegh Nabavi, Andrea Moreno

    Optogenetics has revolutionised neuroscience research, but at the same time has brought a plethora of new variables to consider when designing an experiment with AAV-based targeted gene delivery. Some concerns have been raised regarding the impact of AAV injection volume and expression time in relation to longitudinal experimental designs. In this study, we investigated the efficiency of optically evoked post-synaptic responses in connection to two variables: the volume of the injected virus and the expression time of the virus. For this purpose, we expressed the blue-shifted ChR2, oChIEF, employing a widely used AAV vector delivery strategy. We found that the volume of the injected virus has a minimal impact on the efficiency of optically-evoked postsynaptic population responses. The expression time, on the other hand, has a pronounced effect, with a gradual reduction in the population responses beyond 4 weeks of expression. We strongly advise to monitor time-dependent expression profiles when planning or conducting long-term experiments that depend on successful and stable channelrhodopsin expression.